PSIL vs. ENVB
PSIL (AdvisorShares Psychedelics ETF) is Health & Biotech Equities fund actively managed by AdvisorShares, while ENVB (Enveric Biosciences Inc) is a stock. Over the past 3 years, PSIL returned 6.03%/yr vs -87.52%/yr for ENVB. At a 0.30 correlation, their price movements are largely independent.
Performance
PSIL vs. ENVB - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, PSIL achieves a 12.35% return, which is significantly higher than ENVB's -59.23% return.
PSIL
- 1D
- -4.32%
- 1M
- -3.41%
- YTD
- 12.35%
- 6M
- 10.46%
- 1Y
- 52.66%
- 3Y*
- 6.03%
- 5Y*
- —
- 10Y*
- —
ENVB
- 1D
- -3.27%
- 1M
- -34.22%
- YTD
- -59.23%
- 6M
- -72.39%
- 1Y
- -89.81%
- 3Y*
- -87.52%
- 5Y*
- -85.10%
- 10Y*
- -74.86%
PSIL vs. ENVB - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
PSIL AdvisorShares Psychedelics ETF | 12.35% | 74.55% | -19.50% | -25.12% | -67.24% | -42.72% |
ENVB Enveric Biosciences Inc | -59.23% | -94.37% | -72.43% | -37.50% | -95.53% | -64.91% |
Correlation
The correlation between PSIL and ENVB is 0.27, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.27 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.22 |
Correlation (All Time) Calculated using the full available price history since Sep 16, 2021 | 0.30 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PSIL vs. ENVB — Risk / Return Rank
PSIL
ENVB
PSIL vs. ENVB - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for AdvisorShares Psychedelics ETF (PSIL) and Enveric Biosciences Inc (ENVB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| PSIL | ENVB | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.76 | ||
| Sortino ratioReturn per unit of downside risk | +2.81 | ||
| Omega ratioGain probability vs. loss probability | 1.23 | 0.87 | +0.35 |
| Calmar ratioReturn relative to maximum drawdown | 2.60 | -0.98 | +3.58 |
| Martin ratioReturn relative to average drawdown | 5.38 | -1.34 | +6.73 |
Loading charts...
Drawdowns
PSIL vs. ENVB - Drawdown Comparison
The maximum PSIL drawdown since its inception was -92.72%, smaller than the maximum ENVB drawdown of -100.00%. Use the drawdown chart below to compare losses from any high point for PSIL and ENVB.
Loading charts...
Drawdown Indicators
| PSIL | ENVB | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -92.72% | -100.00% | +7.28% |
Max Drawdown (1Y)Largest decline over 1 year | -20.38% | -91.49% | +71.11% |
Max Drawdown (3Y)Largest decline over 3 years | -64.62% | -99.81% | +35.19% |
Max Drawdown (5Y)Largest decline over 5 years | — | -100.00% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -100.00% | — |
Current DrawdownCurrent decline from peak | -78.15% | -100.00% | +21.85% |
Average DrawdownAverage peak-to-trough decline | -76.71% | -86.07% | +9.36% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 9.81% | 66.73% | -56.92% |
Volatility
PSIL vs. ENVB - Volatility Comparison
The current volatility for AdvisorShares Psychedelics ETF (PSIL) is 12.21%, while Enveric Biosciences Inc (ENVB) has a volatility of 21.07%. This indicates that PSIL experiences smaller price fluctuations and is considered to be less risky than ENVB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| PSIL | ENVB | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 12.21% | 21.07% | -8.86% |
Volatility (6M)Calculated over the trailing 6-month period | 28.74% | 105.59% | -76.85% |
Volatility (1Y)Calculated over the trailing 1-year period | 42.53% | 175.01% | -132.48% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 63.03% | 155.96% | -92.93% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 63.03% | 164.65% | -101.62% |
Dividends
PSIL vs. ENVB - Dividend Comparison
PSIL's dividend yield for the trailing twelve months is around 8.90%, while ENVB has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
ENVB Enveric Biosciences Inc | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
PSIL AdvisorShares Psychedelics ETF | 8.90% | 10.95% | 1.49% | 0.24% | 2.91% |
Frequently Asked Questions
PSIL and ENVB have a correlation of 0.27, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ENVB has higher volatility (21.07%) compared to PSIL (12.21%). In terms of maximum drawdown, PSIL dropped -92.72% vs ENVB's -100.00%.
PSIL currently has the higher Sharpe Ratio (1.25 vs -0.51), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for PSIL and ENVB
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer